Strategic indicators tracking SaudiVax's contribution to the Kingdom's National Biotechnology Strategy — sovereign biomanufacturing capacity, economic diversification, and high-value talent development.
Every operational metric is mapped to the Kingdom's National Biotechnology Strategy objectives.
Eliminating sovereign dependency on imported vaccines through localized 200,000L biomanufacturing infrastructure and BSL-3 containment capability.
Building a new, knowledge-based pillar of the Saudi economy — transitioning from petroleum dependency to biotech sovereignty with $34.6B GDP target.
Cultivating the next generation of Saudi biotech leaders through advanced training programs, university partnerships, and STEM outreach across the Kingdom.
In partnership with the Ministry of Health, our P3 initiative establishes a rapid-response manufacturing platform capable of pivoting facilities within weeks to produce vaccines for emerging infectious threats — creating a vital biological shield for the nation.
Threat-to-response
Containment level
Through collaborations with leading institutions including KAUST, KSU, and McGill University, we offer advanced internships and co-op programs. We are not just creating jobs — we are building careers and retaining the nation's brightest minds in a sector critical for the future.
Scientists trained
University partners
Join us in building Saudi Arabia's biopharmaceutical sovereignty. Whether you bring technology, capital, or expertise — there is a role for you in this national transformation.